Book Chapters
Agarwal N; Guedes M; Pecoits-Filho R; Jardine M, 2022, 'Alternative Clinical Trial Designs for Nephrology Research', in Innovations in Nephrology: Breakthrough Technologies in Kidney Disease Care, pp. 461 - 492, http://dx.doi.org/10.1007/978-3-031-11570-7_28
Smyth B; Hawley CM; Jardine M, 2022, 'Dialysis Dose and Adequacy for Hemodialysis', in Evidence-Based Nephrology, Second Edition: Volumes 1,2, pp. 20 - 33, http://dx.doi.org/10.1002/9781119105954.ch41
Foote C; Jardine MJ, 2014, 'Acute dialysis in older patients', in Managing Renal Injury in the Elderly Patient, pp. 59 - 71, http://dx.doi.org/10.1007/978-3-642-39947-3_7
Wang AY; Jardine M; Perkovic V, 2014, 'Kidney Disease in Diabetes', in Managing Cardiovascular Complications in Diabetes, pp. 58 - 86, http://dx.doi.org/10.1002/9781118337967.ch3
Wang Y; Ivany JN; Perkovic V; Gallagher MP; Jardine MJ, 2012, 'Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease', in Wang Y (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd009631
Gangadharan Komala M; Pianta TJ; Jardine MJ; Webster AC; Perkovic V, 2011, 'Interventions for preventing intradialytic hypotension in haemodialysis patients', in Gangadharan Komala M (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd009459
Razavian M; Di Micco L; Palmer SC; Craig JC; Perkovic V; Zoungas S; Webster AC; Jardine MJ; Strippoli GFM, 2010, 'Antiplatelet agents for chronic kidney disease', in Palmer SC (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd008834
Journal articles
O'Hara DV; Janse RJ; Fu EL; Jardine MJ; Carrero JJ, 2024, 'Adherence and persistence to novel glucose-lowering medications in persons with type 2 diabetes mellitus undergoing routine care', Diabetes Research and Clinical Practice, 213, http://dx.doi.org/10.1016/j.diabres.2024.111745
Pinter J; Jardine M; Canaud B; Genser B, 2024, 'Authors' Reply: Dialysate Sodium and Mortality: 140 mmol/L at Hemodialysis Initiation by Default?', Journal of the American Society of Nephrology, 35, pp. 974 - 975, http://dx.doi.org/10.1681/ASN.0000000000000376
Pinter J; Smyth B; Jardine M, 2024, 'Authors' Reply: Dialysate Sodium and Mortality: One Size Does Not Fit All', Journal of the American Society of Nephrology, 35, pp. 977, http://dx.doi.org/10.1681/ASN.0000000000000405
Patel SM; Kang YM; Im KA; Neuen BL; Anker SD; Bhatt DL; Butler J; Cherney DZI; Claggett BL; Fletcher RA; Herrington WG; Inzucchi SE; Jardine MJ; Mahaffey KW; McGuire DK; McMurray JJV; Neal B; Packer M; Perkovic V; Solomon SD; Staplin N; Vaduganathan M; Wanner C; Wheeler DC; Zannad F; Zhao Y; Heerspink HJL; Sabatine MS; Wiviott SD, 2024, 'Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis', Circulation, 149, pp. 1789 - 1801, http://dx.doi.org/10.1161/CIRCULATIONAHA.124.069568
Pinter J; Neumaier A; Christa M; Canaud B; Mayne K; Stuard S; Jardine M; Smyth B; Genser B, 2024, '#1657 Impact of cumulative fluid and sodium imbalance exposure on cause-specific mortality in hemodialysis', Nephrology Dialysis Transplantation, 39, http://dx.doi.org/10.1093/ndt/gfae069.808
Neuen BL; Claggett BL; Perkovic V; Jardine M; Heerspink HJL; Mahaffey KW; McMurray JJV; Solomon SD; Vaduganathan M, 2024, 'Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From Four Large-Scale Placebo-Controlled Outcome Trials.', Circulation, http://dx.doi.org/10.1161/CIRCULATIONAHA.124.069382
Fussner LA; Flores-Suárez LF; Cartin-Ceba R; Specks U; Cox PG; Jayne DRW; Merkel PA; Walsh M; Paizis K; Walters G; Jardine M; Milton C; Ibraham A; Siva B; Desmond M; Perkovic V; Kurtkoti J; Vilayur E; Cass A; Summers S; Brown F; Ryan J; Kerr P; Noble E; Luxton G; Mudge DW; Hawley C; Johnson DW; Peh CA; Faull RJ; Ranganathan D; Jeffs L; Nicholls K; Hughes P; Cooper B; Boudville N; Ford S; Langham R; Reidlinger D; Morrish A; Badve SV; Pascoe E; Paul-Brent PA; Robison L; Valks A; Blockmans D; Henckaerts L; Sprangers B; Suri R; Brachemi S; Clark W; Garg A; Carette S; Pagnoux C; Reich H; Barth D; Khalidi N; Cox G; Mazzetti A; Robins D; Wald R; Perl J; Pavenski K; Dacouris N; Levin A; Copland M; Fairhead T; Pannu N; Qarni MU; Habib S; Girard L; Manns B; Tesar V; Hruskova Z; Chocova Z; Povlsen J; Gregersen J; Ivarsen P; Birn H; Krarup E; Pedersen EB; Thomsen I; Bech JN; Szpirt W; Egfjord M; Mesbah R; Bataille P; Rey I; Chantrel F; Vanhille P; Quémeneur T; Carron PL; Zaoui P; de Moreuil C; Gosselin M; Delluc A; Hanrotel-Saliou C; Le Jeune M; Ficheux M; Aniort J, 2024, 'Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Results of an International Randomized Controlled Trial (PEXIVAS)', American Journal of Respiratory and Critical Care Medicine, 209, pp. 1141 - 1151, http://dx.doi.org/10.1164/rccm.202308-1426OC
Januzzi JL; Liu Y; Sattar N; Yavin Y; Pollock CA; Butler J; Jardine M; Heerspink HJL; Masson S; Breyer M; Hansen MK, 2024, 'Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial', American Heart Journal, 271, pp. 38 - 47, http://dx.doi.org/10.1016/j.ahj.2024.02.016
Fletcher RA; Herrington WG; Agarwal R; Mayne KJ; Arnott C; Jardine MJ; Mahaffey KW; Perkovic V; Staplin N; Wheeler DC; Chertow GM; Heerspink HJL; Neuen BL, 2024, 'Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression Trials.', Clin J Am Soc Nephrol, http://dx.doi.org/10.2215/CJN.0000000000000470
Mohebi R; Liu Y; Hansen MK; Yavin Y; Sattar N; Pollock CA; Butler J; Jardine M; Masson S; Heerspink HJL; Januzzi JL, 2024, 'Associations of Angiopoietin 2 and Vascular Endothelial Growth Factor-A Concentrations with Clinical End Points', Clinical Journal of the American Society of Nephrology, 19, pp. 429 - 437, http://dx.doi.org/10.2215/CJN.0000000000000389
Toussaint ND; Davies CE; Bongetti E; Ruderman I; Elder GJ; Hawley CM; Krishnasamy R; Roberts MA; Jardine MJ; De Zoysa JR; McDonald SP, 2024, 'Calciphylaxis Episodes in the Australia and New Zealand Dialysis and Transplant Registry', Kidney International Reports, 9, pp. 951 - 959, http://dx.doi.org/10.1016/j.ekir.2024.01.026
Francis A; Wainstein M; Irish G; Abdul Hafidz MI; Chen T; Cho Y; Htay H; Kanjanabuch T; Lalji R; Neuen BL; See E; Shah A; Smyth B; Tungsanga S; Viecelli A; Yeung EK; Arruebo S; Bello AK; Caskey FJ; Damster S; Donner JA; Jha V; Johnson DW; Levin A; Malik C; Nangaku M; Okpechi IG; Tonelli M; Ye F; Wong MG; Bavanandan S; Abdul Gafor AH; Amouzegar A; Bennett P; Chicano SL; Davids MR; Davison SN; Diongole HM; Divyaveer S; Ekrikpo UE; Ethier I; Fong VK; Fung WWS; Ghimire A; Gopal B; Phan HAH; Harris DCH; Houston G; Ibrahim KS; Jardine MJ; Jindal K; Kantachuvesiri S; Kelly DM; Kerr P; Kim S; Krishnasamy R; Kwek JL; Lee V; Liew A; Lim CY; Lydia A; Nalado AM; Olanrewaju TO; Osman MA; Petrova A; Pyar KP; Riaz P; Saad S; Sakajiki AM; Sengthavisouk N; Sozio SM; Srisawat N; Tan E; Tiv S; Tomacruz Amante ID; Villanueva AR; Walker R; Walker R; Zaidi D, 2024, 'Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)', Kidney International Supplements, 13, pp. 110 - 122, http://dx.doi.org/10.1016/j.kisu.2024.01.004
Jenkins AJ; O'Connell RL; Januszewski AS; Webster AC; M.E. Davis T; Jardine MJ; Scott RS; Taskinen MR; Keech AC, 2024, 'Not enough known about fenofibrate's kidney effects in people with Type 2 diabetes', Diabetes Research and Clinical Practice, 210, http://dx.doi.org/10.1016/j.diabres.2024.111612
Smyth B; Krishnasamy R; Jardine M; Hawley C; Jha V; Walsh M; Li Z; Wanner C; Bavanandan S; Wheeler DC; Perkovic V; Rossignol P; Clark C; Kaufman J; Khan BA; Bassi A; Pinter J; Dempsey E; Solano NZ, 2024, 'Are Observational Reports on the Association of Dialysate Sodium with Mortality Enough to Change Practice? Perspective from the RESOLVE Study Team', Journal of the American Society of Nephrology, 35, pp. 229 - 231, http://dx.doi.org/10.1681/ASN.0000000000000289
Koshino A; Neuen BL; Oshima M; Toyama T; Hara A; Arnott C; Neal B; Jardine M; Badve SV; Mahaffey KW; Pollock C; Hansen MK; Wada T; Heerspink HJL, 2024, 'Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial', Kidney International Reports, 9, pp. 347 - 355, http://dx.doi.org/10.1016/j.ekir.2023.11.024
Pinter J; Smyth B; Stuard S; Jardine M; Wanner C; Rossignol P; Wheeler DC; Marshall MR; Canaud B; Genser B, 2024, 'Effect of Dialysate and Plasma Sodium on Mortality in a Global Historical Hemodialysis Cohort', Journal of the American Society of Nephrology, 35, pp. 167 - 176, http://dx.doi.org/10.1681/ASN.0000000000000262
Neuen BL; Jun M; Wick J; Kotwal S; Badve SV; Jardine MJ; Gallagher M; Chalmers J; Nallaiah K; Perkovic V; Peiris D; Rodgers A; Woodward M; Ronksley PE, 2024, 'Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data', The Lancet Regional Health - Western Pacific, 43, http://dx.doi.org/10.1016/j.lanwpc.2023.100988
Jun M; Wick J; Neuen BL; Kotwal S; Badve SV; Woodward M; Chalmers J; Peiris D; Rodgers A; Nallaiah K; Jardine MJ; Perkovic V; Gallagher M; Ronksley PE, 2024, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Kidney International Reports, 9, pp. 312 - 322, http://dx.doi.org/10.1016/j.ekir.2023.11.022
O’Hara DV; Lam CSP; McMurray JJV; Yi TW; Hocking S; Dawson J; Raichand S; Januszewski AS; Jardine MJ, 2024, 'Applications of SGLT2 inhibitors beyond glycaemic control', Nature Reviews Nephrology, http://dx.doi.org/10.1038/s41581-024-00836-y
Vaduganathan M; Cannon CP; Jardine MJ; Heerspink HJL; Arnott C; Neuen BL; Sarraju A; Gogate J; Seufert J; Neal B; Perkovic V; Mahaffey KW; Kosiborod MN, 2024, 'Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trial', European Journal of Heart Failure, http://dx.doi.org/10.1002/ejhf.3292
Yi TW; O’Hara DV; Smyth B; Jardine MJ; Levin A; Morton RL, 2024, 'Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation Research', Canadian Journal of Kidney Health and Disease, 11, http://dx.doi.org/10.1177/20543581231217857
Chertow GM; Chang AM; Felker GM; Heise M; Velkoska E; Fellström B; Charytan DM; Clementi R; Gibson CM; Goodman SG; Jardine M; Levin A; Lokhnygina Y; Mears J; Mehran R; Stenvinkel P; Wang A; Wheeler DC; Zoccali C; Ridker PM; Mahaffey KW; Tricoci P; Wolf M, 2024, 'IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial', Nature Medicine, http://dx.doi.org/10.1038/s41591-024-03043-1
Kim D; Lv J; Hladunewich M; Jha V; Hooi LS; Monaghan H; Shan S; Reich HN; Barbour S; Billot L; Zhang H; Perkovic V; Wong MG; Levin A; Cattran D; Johnson DW; Wheeler D; Flöge J; Woodward M; Jardine M; Zhao MH; Agarwal R; Glassock R; Chan TM; Wu Y; Liu Z, 2024, 'The Efficacy and Safety of Reduced-Dose Oral Methylprednisolone in High-Risk Immunoglobulin A Nephropathy', Kidney International Reports, http://dx.doi.org/10.1016/j.ekir.2024.03.032
Talbot B; Davies S; Burman J; Ritchie A; Snelling P; Lynch S; Park Y; Jones B; Garvey V; Jaure A; Jardine M; Perkovic V; Gallagher M; Brandwood A; Kaur N; Knight J, 2024, 'The Point-of-Care Peritoneal Dialysis System Early Evaluation Study (POC-PDEE): A pilot proof-of-principal study of the Ellen Medical Devices Point-of-Care affordable peritoneal dialysis system', Peritoneal Dialysis International, http://dx.doi.org/10.1177/08968608231209850
Heerspink HJL; Jardine M; Kohan DE; Lafayette RA; Levin A; Liew A; Zhang H; Gray T; Sheth K; Camargo M; Renfurm R; King A; Barratt J, 2024, 'WCN24-2099 BASELINE CHARACTERISTICS OF THE ALIGN TRIAL: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF ATRASENTAN IN PATIENTS WITH IGAN', Kidney International Reports, 9, pp. S183 - S183, http://dx.doi.org/10.1016/j.ekir.2024.02.375
Fletcher RA; Jongs N; Chertow GM; McMurray JJV; Arnott C; Jardine MJ; Mahaffey KW; Perkovic V; Rockenschaub P; Rossing P; Correa-Rotter R; Toto RD; Vaduganathan M; Wheeler DC; Heerspink HJL; Neuen BL, 2023, 'Effect of SGLT2 Inhibitors on Discontinuation of Renin–angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials', Journal of the American Society of Nephrology, 34, pp. 1965 - 1975, http://dx.doi.org/10.1681/ASN.0000000000000248
Mohebi R; Liu Y; Hansen MK; Yavin Y; Sattar N; Pollock CA; Butler J; Jardine M; Masson S; Heerspink HJL; Januzzi JL, 2023, 'Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trial', Cardiovascular Diabetology, 22, http://dx.doi.org/10.1186/s12933-023-01916-2
Liao J; Xiao F; Yang L; Wei Y; Song C; Li J; Yu S; Lu Y; Zhang J; Dai L; Liang W; Li T; Xiong Z; Wu Y; Jardine MJ; Carrero JJ; Shan Y; Huang X, 2023, 'Cystatin C–based estimated glomerular filtration rate and risk of stroke in the general population: a prospective cohort study', Clinical Kidney Journal, 16, pp. 2059 - 2071, http://dx.doi.org/10.1093/ckj/sfad188
Eckardt KU; Delgado C; Heerspink HJL; Pecoits-Filho R; Ricardo AC; Stengel B; Tonelli M; Cheung M; Jadoul M; Winkelmayer WC; Kramer H; Al-Aly Z; Ashuntantang GE; Boor P; Calice da Silva V; Coleman J; Coresh J; Delanaye P; Ebert N; Enghard P; Feldman HI; Fisher L; Flythe JE; Fukui A; Grams ME; Ix JH; Jardine MJ; Jha V; Ju W; Jurish R; Kalyesubula R; Kashihara N; Levey AS; Levin A; Luyckx V; Małyszko J; Manski-Nankervis JA; Navaneethan SD; Obrador G; Ortiz A; Ortiz J; Cardoso Dos Santos BF; Sarnak MJ; Schaeffner E; Selby NM; Simpson DM; Solá L; St. Peter WL; Stevens PE; Tangri N; Tannor EK; Tchokhonelidze I; Wilck N; Wong MMY, 2023, 'Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference', Kidney International, 104, pp. 888 - 903, http://dx.doi.org/10.1016/j.kint.2023.05.013
Young TK; Hockham C; Sukkar L; Kang A; Jun M; Foote C; Baker J; Rogers K; Zoungas S; Cass A; Sullivan D; Jardine MJ, 2023, 'Duration and effectiveness of glucose-lowering regimens in the real world management of diabetes: Data from the Australian EXTEND45 Linked Cohort Study', Endocrine and Metabolic Science, 12, http://dx.doi.org/10.1016/j.endmts.2023.100135
Jun M; Scaria A; Andrade J; Badve SV; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Ha J; Harel Z; Hemmelgarn B; Hockham C; James MT; Jardine MJ; Levin A; Mcarthur E; Ravani P; Shao S; Sood MM; Tan Z; Tangri N; Whitlock R; Gallagher M, 2023, 'Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study', European Heart Journal - Quality of Care and Clinical Outcomes, 9, pp. 621 - 631, http://dx.doi.org/10.1093/ehjqcco/qcac069
Mehrotra R; Davison SN; Farrington K; Flythe JE; Foo M; Madero M; Morton RL; Tsukamoto Y; Unruh ML; Cheung M; Jadoul M; Winkelmayer WC; Brown EA; Bagasha P; Bargman JM; Bavanandan S; Beckwith H; Bennett PN; Bohm C; Brennan F; Burton JO; Cavanaugh KL; Chilcot J; Choi P; Cukor D; Dember LM; Dong J; Edwards D; Erickson KF; Figueiredo A; Finkelstein FO; Fukagawa M; Germain M; Guillano FB; Hurst H; Iseki K; Jardine MJ; Jauré A; Jha V; Jhamb M; Kanjanabuch T; Lerma E; Kam-Tao Li P; Liew A; Małyszko J; Proenca de Moraes T; Moranne O; Nam Ng MS; Ostermann M; Perl J; Pigford J; Pommer W; Richardson MM; Rivara MB; Roberts GV; Sarafidis P; Shroff R; Slon Roblero MF; Smyth B; Søndergaard H; Van Der Veer SN; Vassalotti JA; Vervloet M; Vincent L; Walker R; Warren M; Wasylynuk BA; West M; Wilkie C, 2023, 'Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference', Kidney International, 104, pp. 441 - 454, http://dx.doi.org/10.1016/j.kint.2023.05.019
Kang A; Smyth B; Neuen BL; Heerspink HJL; Di Tanna GL; Zhang H; Arnott C; Hockham C; Agarwal R; Bakris G; Charytan DM; de Zeeuw D; Greene T; Levin A; Pollock C; Wheeler DC; Mahaffey KW; Perkovic V; Jardine MJ, 2023, 'The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trials', Diabetes, Obesity and Metabolism, 25, pp. 2151 - 2162, http://dx.doi.org/10.1111/dom.15091
Fletcher RA; Arnott C; Rockenschaub P; Schutte AE; Carpenter L; Vaduganathan M; Agarwal R; Bakris G; Chang TI; Heerspink HJL; Jardine MJ; Mahaffey KW; Neal B; Pollock C; Jun M; Rodgers A; Perkovic V; Neuen BL, 2023, 'Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials', Journal of the American Heart Association, 12, pp. e028516, http://dx.doi.org/10.1161/JAHA.122.028516
Inker LA; Collier W; Greene T; Miao S; Chaudhari J; Appel GB; Badve SV; Caravaca-Fontán F; Del Vecchio L; Floege J; Goicoechea M; Haaland B; Herrington WG; Imai E; Jafar TH; Lewis JB; Li PKT; Maes BD; Neuen BL; Perrone RD; Remuzzi G; Schena FP; Wanner C; Wetzels JFM; Woodward M; Heerspink HJL; Estacio RO; Hanratty R; Chalmers J; Canetta P; Barrett B; Neal B; Perkovic V; Mahaffey KW; Johnson D; Jardine M; von Eynatten M; Verde E; Verdalles U; Arroyo D; Chapman A; Torres V; Yu A; Brosnahan G; Hannedouche T; Chow KM; Szeto CC; Leung CB; Xie D; Hou FF; Dwyer J; Pohl MA; Raz I; Hunsicker LG; Vanacker A; Malfait T; Maschio G; Locatelli F; Blankestijn PJ; van Zuilen A; Kobayashi F; Makino H; Chan JCN; Andrulli S; Pozzi C; Casartelli D; Praga M; Trujillo H; Cavero T; Sevillano A; Ruggenenti P; Perna A; Carrara F; Keane WF; Manno C; Haynes R; Baigent C; Landray M; Rauen T; Seikrit C; Wied S; Toto RD; de Jong PE; Saddelli M, 2023, 'A meta-analysis of GFR slope as a surrogate endpoint for kidney failure', Nature Medicine, 29, pp. 1867 - 1876, http://dx.doi.org/10.1038/s41591-023-02418-0
Yi TW; Smyth B; Di Tanna GL; Arnott C; Cardoza K; Kang A; Pollock C; Agarwal R; Bakris G; Charytan DM; de Zeeuw D; Heerspink HJL; Neal B; Wheeler DC; Cannon CP; Zhang H; Zinman B; Perkovic V; Levin A; Mahaffey KW; Jardine M; Brenner BM; Greene T; Jardine MJ; Meininger G; Li N; Kolesnyk I; Aizenberg D; Pecoits-Filho R; Cherney D; Obrador G; Chertow G; Chang T; Hawley C; Ji L; Wada T; Jha V; Lim SK; Lim-Abrahan MA; Santos F; Chae DW; Hwang SJ; Vazelov E; Rychlík I; Hadjadj S; Krane V; Rosivall L; De Nicola L; Dreval A; Nowicki M; Schiller A; Distiller L; Górriz JL; Kolesnyk M; David ; Wheeler C; Guerrero RAA; Albisu JP; Alvarisqueta A; Bartolacci I; Berli MA; Bordonava A; Calella P; Cantero MC; Cartasegna LR; Cercos E; Coloma GC; Colombo H; Commendatore V; Cuadrado J; Cuneo CA; Cusumano AM; Douthat WG; Dran RD; Farias E; Fernandez MF; Finkelstein H; Fragale G; Fretes JO; Garcia NH; Gastaldi A; Gelersztein E; Glenny JA; Gonzalez JP; Colaso PDCG; Goycoa C; Greloni GC; Guinsburg A; Hermida S; Juncos LI; Klyver MI; Kraft F; Krynski F; Lanchiotti PV; Leon de la Fuente RA; Marchetta N; Mele P; Nicolai S; Novoa PA; Orio SI, 2023, 'Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial', American Journal of Kidney Diseases, 82, pp. 84 - 96.e1, http://dx.doi.org/10.1053/j.ajkd.2022.12.015
Ha JT; Scaria A; Andrade J; Badve SV; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Harel Z; Hemmelgarn B; Hockham C; James MT; Jardine MJ; Lam D; Levin A; McArthur E; Ravani P; Shao S; Sood MM; Tan Z; Tangri N; Whitlock R; Gallagher M; Jun M, 2023, 'Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada', Kidney Medicine, 5, http://dx.doi.org/10.1016/j.xkme.2023.100675
Charytan DM; Mahaffey KW; Jardine MJ; Cannon CP; Neal B; Lambers Heerspink HJ; Agarwal R; Bakris GL; De Zeeuw D; Levin A; Pollock C; Zhang H; Zinman B; Rosenthal N; Perkovic V; Di Tanna GL; Yu J; Rogers K; Arnott C; Wheeler DC, 2023, 'Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering', BMJ Open Diabetes Research and Care, 11, pp. e003270, http://dx.doi.org/10.1136/bmjdrc-2022-003270
van der Hoek S; Jongs N; Oshima M; Neuen BL; Stevens J; Perkovic V; Levin A; Mahaffey KW; Pollock C; Greene T; Wheeler DC; Jardine MJ; Heerspink HJL, 2023, 'Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE Trial', Clinical journal of the American Society of Nephrology : CJASN, 18, pp. 748 - 758, http://dx.doi.org/10.2215/CJN.0000000000000161
Payne T; Coburn M; Dieleman S; Heller G; Jardine M; Shehabi Y; Sanders RD, 2023, 'The impact of dexmedetomidine on postoperative delirium: should we throw out a DECADE of research?', British Journal of Anaesthesia, 130, pp. e479 - e481, http://dx.doi.org/10.1016/j.bja.2023.02.040
Heerspink HJL; Radhakrishnan J; Alpers CE; Barratt J; Bieler S; Diva U; Inrig J; Komers R; Mercer A; Noronha IL; Rheault MN; Rote W; Rovin B; Trachtman H; Trimarchi H; Wong MG; Perkovic V; Alarmartine E; Chae DW; Del Vecchio L; Floege J; Hwang SJ; Jelakovic B; Maes B; Malecki R; Miglinas M; Nolasco FEB; Praga M; Rabindranath K; Rosenberg M; Tang SCW; Tesar V; Bose B; Gangadharan M; McDonald S; Peh C; Jahan S; Yeap C; Clayton P; Irish G; Thyagarajan N; Hollett P; Krishnasamy R; Carroll R; Jesudason S; Crail S; Coates T; Waugh J; Noble E; Mahadevan K; Campbell V; Salehi T; Lim W; Boudville N; Chakera A; Chan D; Krishnan A; Eqbal Y; Gillies A; Vilayur E; Maung Myint TM; Gray N; Cheetham M; Pollock C; Cooper B; Mather A; Roxburgh S; Shen Y; Stangenberg S; Siriwardana A; O'Lone E; Wan S; Neuen B; Tsun Kit Ha J; Kim D; Heath L; Jain A; Phua E; Li Y; Gallagher M; Jardine M; Ritchie A; Razavian M; Foote C; Wyndham R; Sen S; Endre Z; Erlich J; Fernando M; Yong K; Luxton G; Kotwal S; Roger S; Wijeratne V; Packham D; Fraser I; Vandewiele B; Laute M; Lemahieu W; Jamar S, 2023, 'Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial', The Lancet, 401, pp. 1584 - 1594, http://dx.doi.org/10.1016/S0140-6736(23)00569-X
Koshino A; Oshima M; Arnott C; Fletcher RA; Bakris GL; Jardine M; Mahaffey KW; Perkovic V; Pollock C; Heerspink HJL; Neuen BL, 2023, 'Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial', Diabetes, Obesity and Metabolism, 25, pp. 1413 - 1418, http://dx.doi.org/10.1111/dom.14978
Collister D; Pyne L; Bhasin AA; Ahmed SB; Smyth B; Herrington W; Jardine M; Walsh M, 2023, 'Sex and Gender in Randomized Controlled Trials of Adults Receiving Maintenance Dialysis: A Meta-epidemiologic Study', American Journal of Kidney Diseases, 81, pp. 575 - 582.e1, http://dx.doi.org/10.1053/j.ajkd.2022.10.015
Back to profile page
https://orcid.org/0000-0002-0160-2375